BIG1, a brefeldin A-inhibited guanine nucleotide-exchange protein modulates ATP-binding cassette transporter A-1 trafficking and function

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 33, Issue 2, 2013, Pages

  Lin, Sisi ^a,d   Zhou, Chun ^a   Neufeld, Edward ^c   Wang, Yu Hua ^a   Xu, Suo Wen ^b   Lu, Liang ^a   Wang, Ying ^a   Liu, Zhi Ping ^a   Li, Dong ^a   Li, Cuixian ^a   Chen, Shaorui ^a   Le, Kang ^b   Huang, Heqing ^a   Liu, Peiqing ^a   Moss, Joel ^b   Vaughan, Martha ^b   Shen, Xiaoyan ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b Cardiovascular and Pulmonary Branch   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^d ZHEJIANG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

ABCA1; BIG1; cholesterol efflux; trafficking

Indexed keywords

ABC TRANSPORTER A1; ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR 1; BREFELDIN A INHIBITED GUANINE NUCLEOTIDE EXCHANGE PROTEIN 1; CHOLESTEROL; GLUTATHIONE; GUANINE NUCLEOTIDE EXCHANGE FACTOR; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BIOTINYLATION; CELL LEVEL; CELL STRAIN HEPG2; CELL SURFACE; CELLULAR DISTRIBUTION; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INTERNALIZATION; LIVER; MEMBRANE VESICLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; RAT;

ADP-RIBOSYLATION FACTOR 1; ANIMALS; APOLIPOPROTEIN A-I; ATP BINDING CASSETTE TRANSPORTER 1; ATP-BINDING CASSETTE TRANSPORTERS; BIOTINYLATION; CELL MEMBRANE; CHOLESTEROL; GLUTATHIONE; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HELA CELLS; HEP G2 CELLS; HUMANS; IMMUNOPRECIPITATION; LIPOPROTEINS, LDL; LIVER; MALE; PROTEIN TRANSPORT; RATS; RATS, SPRAGUE-DAWLEY; RNA INTERFERENCE; TIME FACTORS; TRANSFECTION;

EID: 84872960042     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.112.300720     Document Type: Article

References (45)

1. Oram JF, Vaughan AM. ATP-Binding cassette cholesterol transporters and cardiovascular disease. Circ Res. 2006;99:1031-1043.
2. Bodzioch M, Orsó E, Klucken J, et al. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Genet. 1999;22:347-351.
3. Yang J, Chang E, Cherry AM, Bangs CD, Oei Y, Bodnar A, Bronstein A, Chiu CP, Herron GS. Human endothelial cell life extension by telomer-ase expression. J Biol Chem. 1999;274:26141-26148.
4. Attie AD. ABCA1: at the nexus of cholesterol, HDL and atherosclerosis. Trends Biochem Sci. 2007;32:172-179.
5. Neufeld EB, Stonik JA, Demosky SJ Jr, Knapper CL, Combs CA, Cooney A, Comly M, Dwyer N, Blanchette-Mackie J, Remaley AT, Santamarina-Fojo S, Brewer HB Jr. The ABCA1 transporter modulates late endocytic traffcking: insights from the correction of the genetic defect in Tangier disease. J Biol Chem. 2004;279:15571-15578.
6. Neufeld EB, Remaley AT, Demosky SJ, Stonik JA, Cooney AM, Comly M, Dwyer NK, Zhang M, Blanchette-Mackie J, Santamarina-Fojo S, Brewer HB Jr. Cellular localization and traffcking of the human ABCA1 transporter. J Biol Chem. 2001;276:27584-27590.
7. Singaraja RR, Visscher H, James ER, Chroni A, Coutinho JM, Brunham LR, Kang MH, Zannis VI, Chimini G, Hayden MR. Specifc mutations in ABCA1 have discrete effects on ABCA1 function and lipid pheno-types both in vivo and in vitro. Circ Res. 2006;99:389-397.
8. Witting SR, Maiorano JN, Davidson WS. Ceramide enhances cholesterol effux to apolipoprotein A-I by increasing the cell surface presence of ATP-binding cassette transporter A1. J Biol Chem. 2003;278: 40121-40127.
9. Singaraja RR, Kang MH, Vaid K, Sanders SS, Vilas GL, Arstikaitis P, Coutinho J, Drisdel RC, El-Husseini AD, Green WN, Berthiaume L, Hayden MR. Palmitoylation of ATP-binding cassette transporter A1 is essential for its traffcking and function. Circ Res. 2009;105:138-147.
10. Chen W, Wang N, Tall AR. A PEST deletion mutant of ABCA1 shows impaired internalization and defective cholesterol effux from late endo-somes. J Biol Chem. 2005;280:29277-29281.
11. Linder MD, Uronen RL, Hölttä-Vuori M, van der Sluijs P, Peränen J, Ikonen E. Rab8-dependent recycling promotes endosomal cholesterol removal in normal and sphingolipidosis cells. Mol Biol Cell. 2007;18:47-56.
12. Linder MD, Mäyränpää MI, Peränen J, Pietilä TE, Pietiäinen VM, Uronen RL, Olkkonen VM, Kovanen PT, Ikonen E. Rab8 regulates ABCA1 cell surface expression and facilitates cholesterol effux in primary human macrophages. Arterioscler Thromb Vasc Biol. 2009;29:883-888.
13. Mendez AJ. Monensin and brefeldin A inhibit high density lipoprotein-mediated cholesterol effux from cholesterol-enriched cells. Implications for intracellular cholesterol transport. J Biol Chem. 1995;270:5891-5900.
14. Remaley AT, Schumacher UK, Stonik JA, Farsi BD, Nazih H, Brewer HB Jr. Decreased reverse cholesterol transport from Tangier disease fbroblasts. Acceptor specifcity and effect of brefeldin on lipid effux. Arterioscler Thromb Vasc Biol. 1997;17:1813-1821.
15. Klausner RD, Donaldson JG, Lippincott-Schwartz J. Brefeldin A: insights into the control of membrane traffc and organelle structure. J Cell Biol. 1992;116:1071-1080.
16. Mossessova E, Corpina RA, Goldberg J. Crystal structure of ARF1&z.ast;Sec7 complexed with Brefeldin A and its implications for the guanine nucleo-tide exchange mechanism. Mol Cell. 2003;12:1403-1411.
17. Ishizaki R, Shin HW, Mitsuhashi H, Nakayama K. Redundant roles of BIG2 and BIG1, guanine-nucleotide exchange factors for ADP-ribosylation factors in membrane traffc between the trans-Golgi network and endosomes. Mol Biol Cell. 2008;19:2650-2660.
18. Shen X, Xu KF, Fan Q, Pacheco-Rodriguez G, Moss J, Vaughan M. Association of brefeldin A-inhibited guanine nucleotide-exchange protein 2 (BIG2) with recycling endosomes during transferrin uptake. Proc Natl Acad Sci USA. 2006;103:2635-2640.
19. Zhao X, Claude A, Chun J, Shields DJ, Presley JF, Melançon P. GBF1, a cis-Golgi and VTCs-localized ARF-GEF, is implicated in ER-to-Golgi protein traffc. J Cell Sci. 2006;119:3743-3753.
20. Zha X, Gauthier A, Genest J, McPherson R. Secretory vesicular transport from the Golgi is altered during ATP-binding cassette protein A1 (ABCA1)-mediated cholesterol effux. J Biol Chem. 2003;278:10002-10005.
21. Yamaji R, Adamik R, Takeda K, Togawa A, Pacheco-Rodriguez G, Ferrans VJ, Moss J, Vaughan M. Identifcation and localization of two brefeldin A-inhibited guanine nucleotide-exchange proteins for ADP-ribosylation factors in a macromolecular complex. Proc Natl Acad Sci USA. 2000;97:2567-2572.
22. Zhao X, Lasell TK, Melançon P. Localization of large ADP-ribosylation factor-guanine nucleotide exchange factors to different Golgi compartments: evidence for distinct functions in protein traffc. Mol Biol Cell. 2002;13:119-133.
23. Langmann T, Klucken J, Reil M, Liebisch G, Luciani MF, Chimini G, Kaminski WE, Schmitz G. Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages. Biochem Biophys Res Commun. 1999;257:29-33.
24. Orsó E, Broccardo C, Kaminski WE, et al. Transport of lipids from golgi to plasma membrane is defective in tangier disease patients and Abc1-defcient mice. Nat Genet. 2000;24:192-196.
25. Brunham LR, Singaraja RR, Duong M, Timmins JM, Fievet C, Bissada N, Kang MH, Samra A, Fruchart JC, McManus B, Staels B, Parks JS, Hayden MR. Tissue-specifc roles of ABCA1 infuence susceptibility to atherosclerosis. Arterioscler Thromb Vasc Biol. 2009;29:548-554.
26. Nachtigal P, Pospisilova N, Vecerova L, Micuda S, Brcakova E, Pospechova K, Semecky V. Atorvastatin increases endoglin, SMAD2, phosphorylated SMAD2/3 and eNOS expression in apoE/LDLR double knockout mice. J Atheroscler Thromb. 2009;16:265-274.
27. Chawla A, Boisvert WA, Lee CH, Lafftte BA, Barak Y, Joseph SB, Liao D, Nagy L, Edwards PA, Curtiss LK, Evans RM, Tontonoz P. A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol effux and atherogenesis. Mol Cell. 2001;7:161-171.
28. Arakawa R, Yokoyama S. Helical apolipoproteins stabilize ATP-binding cassette transporter A1 by protecting it from thiol protease-mediated degradation. J Biol Chem. 2002;277:22426-22429.
29. Lu R, Arakawa R, Ito-Osumi C, Iwamoto N, Yokoyama S. ApoA-I facilitates ABCA1 recycle/accumulation to cell surface by inhibiting its intra-cellular degradation and increases HDL generation. Arterioscler Thromb Vasc Biol. 2008;28:1820-1824.
30. Azuma Y, Takada M, Shin HW, Kioka N, Nakayama K, Ueda K. Retroendocytosis pathway of ABCA1/apoA-I contributes to HDL formation. Genes Cells. 2009;14:191-204.
31. Tanaka AR, Kano F, Yamamoto A, Ueda K, Murata M. Formation of cholesterol-enriched structures by aberrant intracellular accumulation of ATP-binding cassette transporter A1. Genes Cells. 2008;13: 889-904.
32. Casanova JE. Regulation of Arf activation: the Sec7 family of guanine nucleotide exchange factors. Traffc. 2007;8:1476-1485.
33. Wellington CL, Brunham LR, Zhou S, Singaraja RR, Visscher H, Gelfer A, Ross C, James E, Liu G, Huber MT, Yang YZ, Parks RJ, Groen A, Fruchart-Najib J, Hayden MR. Alterations of plasma lipids in mice via adenoviral-mediated hepatic overexpression of human ABCA1. J Lipid Res. 2003;44:1470-1480.
34. Basso F, Freeman L, Knapper CL, Remaley A, Stonik J, Neufeld EB, Tansey T, Amar MJ, Fruchart-Najib J, Duverger N, Santamarina-Fojo S, Brewer HB Jr. Role of the hepatic ABCA1 transporter in modulating intrahepatic cholesterol and plasma HDL cholesterol concentrations. J Lipid Res. 2003;44:296-302.
35. Timmins JM, Lee JY, Boudyguina E, Kluckman KD, Brunham LR, Mulya A, Gebre AK, Coutinho JM, Colvin PL, Smith TL, Hayden MR, Maeda N, Parks JS. Targeted inactivation of hepatic ABCA1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I. J Clin Invest. 2005;115:1333-1342.
36. Haghpassand M, Bourassa PA, Francone OL, Aiello RJ. Monocyte/mac-rophage expression of ABCA1 has minimal contribution to plasma HDL levels. J Clin Invest. 2001;108:1315-1320.
37. Helms JB, Rothman JE. Inhibition by brefeldin A of a Golgi membrane enzyme that catalyses exchange of guanine nucleotide bound to ARF. Nature. 1992;360:352-354.
38. Venkateswaran A, Lafftte BA, Joseph SB, Mak PA, Wilpitz DC, Edwards PA, Tontonoz P. Control of cellular cholesterol effux by the nuclear oxysterol receptor LXR alpha. Proc Natl Acad Sci USA. 2000;97:12097-12102.
39. Shen X, Hong MS, Moss J, Vaughan M. BIG1, a brefeldin A-inhibited guanine nucleotide-exchange protein, is required for correct gly-cosylation and function of integrin beta1. Proc Natl Acad Sci USA. 2007;104:1230-1235.
40. Shen X, Meza-Carmen V, Puxeddu E, Wang G, Moss J, Vaughan M. Interaction of brefeldin A-inhibited guanine nucleotide-exchange protein (BIG) 1 and kinesin motor protein KIF21A. Proc Natl Acad Sci USA. 2008;105:18788-18793.
41. Kang MH, Singaraja R, Hayden MR. Adenosine-triphosphate-binding cassette transporter-1 traffcking and function. Trends Cardiovasc Med. 2010;20:41-49.
42. Moss J, Vaughan M. Molecules in the ARF orbit. J Biol Chem. 1998;273:21431-21434.
43. Engel T, Lueken A, Bode G, Hobohm U, Lorkowski S, Schlueter B, Rust S, Cullen P, Pech M, Assmann G, Seedorf U. ADP-ribosylation factor (ARF)-like 7 (ARL7) is induced by cholesterol loading and participates in apoli-poprotein AI-dependent cholesterol export. FEBS Lett. 2004;566:241-246.
44. Yu X, Breitman M, Goldberg J. A structure-based mechanism for Arf1-dependent recruitment of coatomer to membranes. Cell. 2012;148:530-542.
45. Beers MF, Hawkins A, Shuman H, Zhao M, Newitt JL, Maguire JA, Ding W, Mulugeta S. A novel conserved targeting motif found in ABCA transporters mediates traffcking to early post-Golgi compartments. J Lipid Res. 2011;52:1471-1482.